Literature DB >> 16140740

Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.

John W Schoggins1, Marcelo Nociari, Nicola Philpott, Erik Falck-Pedersen.   

Abstract

The major adenovirus (Ad) capsid proteins hexon, penton, and fiber influence the efficiency and tropism of gene transduction by Ad vectors. Fiber is the high-affinity receptor binding protein that serves to mediate cell attachment in vitro when using coxsackie-adenovirus receptor (CAR)-containing cell lines. This contrasts with transduction efficiency in macrophages or dendritic cells that lack high concentrations of CAR. To determine how fiber influences gene transduction and immune activation in a murine model, we have characterized Ad type 5 (Ad5) vectors with two classes of chimeric fiber, CAR binding and non-CAR binding. In a systemic infection, Ad5 fiber contributes to DNA localization and vector transduction in hepatic tissue. However, the majority of vector localization is due to Ad5 fiber-specific functions distinct from CAR binding. CAR-directed transduction occurs but at a modest level. In contrast to CAR binding vectors, the F7 and F7F41S non-CAR-binding vectors demonstrate a 2-log decrease in hepatic transduction, with a 10-fold decrease in the amount of vector DNA localizing to the hepatic tissue. To characterize the innate response to early infection using fiber chimeric vectors, intrahepatic cytokine and chemokine mRNAs were quantified 5 hours postinfection. Tumor necrosis factor alpha mRNA levels resulting from Ad5 fiber infections were elevated compared to viruses expressing serotype 7 or 41 fiber. Levels of chemokine mRNA (gamma interferon-inducible protein 10, T-cell activation gene 3, and macrophage inflammatory protein 1beta) were 10- to 20-fold higher with CAR binding vectors (Ad5 and F41T) than with non-CAR-binding vectors (F7 and F7F41S). In spite of quantitative differences in vector localization and innate activation, fiber pseudotyping did not significantly change the outcome of anti-Ad adaptive immunity. All vectors were cleared with the same kinetics as wild-type Ad5 vectors, and each induced neutralizing antibody. Although non-CAR-binding vectors were impaired in transduction by nearly 2 orders of magnitude, the level of antitransgene immunity was the same for each of the vectors. Using primary bone marrow-derived macrophages and dendritic cells, we demonstrate that transduction, induction of cytokine/chemokine, and phenotypic maturation of these antigen-presenting cells are independent of fiber content. Our data support a model where fiber-mediated hepatic localization enhances innate responses to virus infection but minimally impacts on adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140740      PMCID: PMC1212603          DOI: 10.1128/JVI.79.18.11627-11637.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR.

Authors:  M C Bewley; K Springer; Y B Zhang; P Freimuth; J M Flanagan
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

2.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

Authors:  Y Zhang; N Chirmule; G P Gao; R Qian; M Croyle; B Joshi; J Tazelaar; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

4.  Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.

Authors:  P Leissner; V Legrand; Y Schlesinger; D A Hadji; M van Raaij; S Cusack; A Pavirani; M Mehtali
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

5.  TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.

Authors:  J M Trevejo; M W Marino; N Philpott; R Josien; E C Richards; K B Elkon; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset.

Authors:  D Rea; F H Schagen; R C Hoeben; M Mehtali; M J Havenga; R E Toes; C J Melief; R Offringa
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway.

Authors:  A E Morelli; A T Larregina; R W Ganster; A F Zahorchak; J M Plowey; T Takayama; A J Logar; P D Robbins; L D Falo; A W Thomson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.

Authors:  H Mizuguchi; N Koizumi; T Hosono; A Ishii-Watabe; E Uchida; N Utoguchi; Y Watanabe; T Hayakawa
Journal:  Gene Ther       Date:  2002-06       Impact factor: 5.250

9.  In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Authors:  Theodore Smith; Neeraja Idamakanti; Helen Kylefjord; Michele Rollence; Laura King; Michele Kaloss; Michael Kaleko; Susan C Stevenson
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

10.  Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

Authors:  M C Dechecchi; P Melotti; A Bonizzato; M Santacatterina; M Chilosi; G Cabrini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

View more
  24 in total

1.  Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Authors:  Folkert Steinhagen; Corinna Meyer; Debra Tross; Mayda Gursel; Takahiro Maeda; Sven Klaschik; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2012-07-02       Impact factor: 4.962

Review 2.  Progress on adenovirus-vectored universal influenza vaccines.

Authors:  Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 4.  Current strategies and future directions for eluding adenoviral vector immunity.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

5.  Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.

Authors:  Andrea Hesse; Daniela Kosmides; Roland E Kontermann; Dirk M Nettelbeck
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

6.  Recent advances of oncolytic virus in cancer therapy.

Authors:  Moumita Mondal; Jingao Guo; Ping He; Dongming Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

7.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

8.  Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.

Authors:  Elena A Kashentseva; Joanne T Douglas; Kurt R Zinn; David T Curiel; Igor P Dmitriev
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

Review 9.  The influence of innate and pre-existing immunity on adenovirus therapy.

Authors:  Anne K Zaiss; Hidevaldo B Machado; Harvey R Herschman
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

10.  Adenoviral vectors for improved gene delivery to the inner ear.

Authors:  Mark Praetorius; Douglas E Brough; Chi Hsu; Peter K Plinkert; Susanna C Pfannenstiel; Hinrich Staecker
Journal:  Hear Res       Date:  2008-12-07       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.